Today's Date: March 28, 2024
JAMS Diversity Fellowship Accepting Applications   •   80 M/other Artists Converge for MICAfest 2024 in Northampton, MA this May   •   BNSF Railway builds upon safety record by utilizing virtual reality for training   •   Gale Primary Sources Release Four New Archives Devoted to Contributions from Underrecognized Communities   •   New Report Shows Massachusetts Customers Could Have Saved Hundreds of Millions in 2024 Through Competitive Energy Supply   •   Chevron Announces Opening of Fab Labs at HBCUs   •   More $10-a-day child care spaces   •   PMI Foods Gives Easter Donation of 15,000 Pounds of Prime Rib to New Life Church in Arkansas   •   Federal Home Loan Bank of Dallas and Wells Fargo Bank Award $850K for Rio Manor Apartments Renovation   •   Taro Pharmaceuticals U.S.A., Inc. Expands OTC Portfolio for Children with the Introduction of bébé Bottoms™   •   Scotiabank ranks on The Globe and Mail's annual Women Lead Here benchmark of executive gender diversity for the fourth consecuti   •   Consolidated Credit Launches Free Webinar Series to Empower Individuals During Challenging Economic Climate   •   UC Berkeley FHL Vive Center Teams Up with BeamNG   •   Argonne-Supported Critical Materials Assessment Tags Potential Supply Chain Bottlenecks   •   Bill Introduced in Minnesota Would Increase Access To Genetic Testing   •   Paralyzed Veterans of America to honor former Senator Elizabeth Dole with 2024 Gordon H. Mansfield Congressional Leadership Awar   •   American Water Charitable Foundation Announces National Partnership With American Red Cross With $250,000 Donation   •   University of Phoenix Receives Arizona Veteran Supportive Campus Recertification   •   Pushing Policy: Women Uniting for Legislative Change; Four Trailblazing women at the forefront of the Quad Caucus   •   Impacts of Extreme Weather on Interior Design Examined in New Research
Bookmark and Share

ReCode Therapeutics to Present at BMO Biopharma Spotlight Series: Novel Technologies for the Delivery of Genetic Medicines

MENLO PARK, Calif. , March 21 /Businesswire/ - ReCode Therapeutics, a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, today announced that David Lockhart, Ph.D., President and Chief Scientific Officer of ReCode Therapeutics, will participate in a panel discussion titled “Novel LNPs Targeting Diverse Tissues” at 10:00 a.m. ET on Tuesday, March 28, 2023 at the virtual BMO Biopharma Spotlight Series: Novel Technologies for the Delivery of Genetic Medicines.

About ReCode Therapeutics

ReCode Therapeutics is a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation, genetic medicines technology that enables precise delivery to target organs and cells beyond the liver. The SORT LNP platform is the foundation for ReCode’s pipeline of disease-modifying mRNA and gene correction therapeutics. ReCode’s lead programs are focused on primary ciliary dyskinesia and cystic fibrosis. ReCode is leveraging its SORT LNP platform and nucleic acid technologies to expand its pipeline with therapeutics that use mRNA-mediated replacement and gene correction in target organs with precision targeting of disease-relevant cells. For more information, visit www.recodetx.com and follow us on Twitter @ReCodeTx and on LinkedIn.


STORY TAGS: Health, Genetics, Research, Pharmaceutical, Science, Biotechnology, Conference, Webcast, California, United States, North America,

Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News